[Current status and advances in adjuvant therapy after curative resection for pancreatic neuroendocrine tumors: from recurrence risk identification to therapeutic decision-making].
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.